Sustained efficacy and safety of agomelatine versus placebo over 24 weeks in elderly out-patients suffering from major depressive disorder

Authors
Category Primary study
JournalEuropean Neuropsychopharmacology
Year 2014
This article has no abstract
Epistemonikos ID: e4d22ffd54cf8e399a6007318e365a9c373a514e
First added on: Feb 06, 2025